Filing Details
- Accession Number:
- 0001214659-20-010387
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-14 17:42:39
- Reporting Period:
- 2020-12-10
- Accepted Time:
- 2020-12-14 17:42:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1581280 | Twist Bioscience Corp | TWST | Biological Products, (No Disgnostic Substances) (2836) | 462058888 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1755793 | Patrick Weiss | C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-10 | 131 | $5.95 | 54,481 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-10 | 131 | $138.62 | 54,350 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-10 | 3,419 | $8.82 | 57,769 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-10 | 3,419 | $138.62 | 54,350 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-11 | 135 | $5.95 | 54,485 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-11 | 135 | $151.13 | 54,350 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-11 | 3,423 | $8.82 | 57,773 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-11 | 3,423 | $151.13 | 54,350 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-12-10 | 131 | $0.00 | 131 | $5.95 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-12-10 | 3,419 | $0.00 | 3,419 | $8.82 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-12-11 | 135 | $0.00 | 135 | $5.95 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-12-11 | 3,423 | $0.00 | 3,423 | $8.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 135 | 2025-09-28 | No | 4 | M | Direct | |
| 30,774 | 2027-09-28 | No | 4 | M | Direct | |
| 0 | 2025-09-28 | No | 4 | M | Direct | |
| 27,351 | 2027-09-28 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 9, 2020.
- The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Billionaire Hedge Funds
